BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21944293)

  • 1. Uncovering the truth about covered stents: is there a difference between covered versus uncovered stents with transjugular intrahepatic portosystemic shunts?
    Clark W; Golkar F; Luberice K; Toomey P; Paul H; Marcadis A; Okpaleke C; Vice M; Hernandez J; Alsina A; Rosemurgy AS
    Am J Surg; 2011 Nov; 202(5):561-4. PubMed ID: 21944293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents.
    Ockenga J; Kroencke TJ; Schuetz T; Plauth M; Kasim E; Petersein J; Schmidt HH; Lochs H
    Scand J Gastroenterol; 2004 Oct; 39(10):994-9. PubMed ID: 15513340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is sonographic surveillance of polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts (TIPS) necessary? A single centre experience comparing both types of stents.
    Pan JJ; Chen C; Geller B; Firpi R; Machicao VI; Caridi JG; Nelson DR; Morelli G
    Clin Radiol; 2008 Oct; 63(10):1142-8. PubMed ID: 18774362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis.
    Yang Z; Han G; Wu Q; Ye X; Jin Z; Yin Z; Qi X; Bai M; Wu K; Fan D
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1718-25. PubMed ID: 21039832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome.
    Hernández-Guerra M; Turnes J; Rubinstein P; Olliff S; Elias E; Bosch J; García-Pagán JC
    Hepatology; 2004 Nov; 40(5):1197-202. PubMed ID: 15486923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome.
    Darwish Murad S; Luong TK; Pattynama PM; Hansen BE; van Buuren HR; Janssen HL
    Liver Int; 2008 Feb; 28(2):249-56. PubMed ID: 18251982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.
    Bureau C; Garcia Pagan JC; Layrargues GP; Metivier S; Bellot P; Perreault P; Otal P; Abraldes JG; Peron JM; Rousseau H; Bosch J; Vinel JP
    Liver Int; 2007 Aug; 27(6):742-7. PubMed ID: 17617116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic shunt flow reduction with adjustable polytetrafluoroethylene-covered balloon-expandable stents.
    Kroma G; Lopera J; Cura M; Suri R; El-Merhi F; Reading J
    J Vasc Interv Radiol; 2009 Jul; 20(7):981-6. PubMed ID: 19497763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments.
    Tripathi D; Redhead D
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1127-33. PubMed ID: 17033430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents.
    Tripathi D; Ferguson J; Barkell H; Macbeth K; Ireland H; Redhead DN; Hayes PC
    Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):225-32. PubMed ID: 16462534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial.
    Riggio O; Ridola L; Angeloni S; Cerini F; Pasquale C; Attili AF; Fanelli F; Merli M; Salvatori FM
    J Hepatol; 2010 Aug; 53(2):267-72. PubMed ID: 20537753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.
    Bureau C; Garcia-Pagan JC; Otal P; Pomier-Layrargues G; Chabbert V; Cortez C; Perreault P; Péron JM; Abraldes JG; Bouchard L; Bilbao JI; Bosch J; Rousseau H; Vinel JP
    Gastroenterology; 2004 Feb; 126(2):469-75. PubMed ID: 14762784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.
    Perarnau JM; Le Gouge A; Nicolas C; d'Alteroche L; Borentain P; Saliba F; Minello A; Anty R; Chagneau-Derrode C; Bernard PH; Abergel A; Ollivier-Hourmand I; Gournay J; Ayoub J; Gaborit C; Rusch E; Giraudeau B;
    J Hepatol; 2014 May; 60(5):962-8. PubMed ID: 24480619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular Intrahepatic Portosystemic Shunts in Patients with Cirrhosis with Refractory Ascites: Comparison of Clinical Outcomes by Using 8- and 10-mm PTFE-covered Stents.
    Miraglia R; Maruzzelli L; Tuzzolino F; Petridis I; D'Amico M; Luca A
    Radiology; 2017 Jul; 284(1):281-288. PubMed ID: 28121521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Added Value of Covered Stents in Transjugular Intrahepatic Portosystemic Shunt: A Large Single-Center Experience.
    Gupta AC; Wang W; Shah C; Sands MJ; Bullen J; Remer EM; Bayona PM; Carey W; Kapoor B
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1723-1731. PubMed ID: 28512687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
    Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites: a retrospective cohort study.
    Maleux G; Perez-Gutierrez NA; Evrard S; Mroue A; Le Moine O; Laleman W; Nevens F
    Acta Gastroenterol Belg; 2010; 73(3):336-41. PubMed ID: 21086935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results.
    Geeroms B; Laleman W; Laenen A; Heye S; Verslype C; van der Merwe S; Nevens F; Maleux G
    Eur Radiol; 2017 May; 27(5):1795-1803. PubMed ID: 27629421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.